T1	intervention 17 33	aerobic exercise
T2	condition 112 126	cardiotoxicity
T3	total-participants 451 462	Twenty-four
T4	eligibility 463 499	women with early stage breast cancer
T5	control 658 668	usual care
T6	outcome 1006 1083	doxorubicin-related change in longitudinal strain, twist, or cardiac troponin
T7	outcome 1134 1157	changes in hemodynamics
T11	outcome 1417 1434	No adverse events
T8	outcome 1267 1283	body weight gain
T9	outcome 1285 1313	prevalence of depressed mood
T10	outcome 1315 1327	sore muscles
T12	outcome 1333 1346	low back pain
